GO
Loading...

Mallinckrodt CEO Celebrates Spinoff

Monday, 1 Jul 2013 | 9:47 AM ET

Marc Trudeau, Mallinckrodt Pharmaceuticals CEO, talks with CNBC about his company's debut on the NYSE and discusses various growth products in its pipeline.